Immediate Impact
1 standout
Citing Papers
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
2024 Standout
Works of David Wullimann being referenced
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Wullimann | 27 | 23 | 10 | 7 | 47 | |
| Mariella D’Angiò | 14 | 16 | 5 | 8 | 53 | |
| Margherita Oberti | 31 | 27 | 8 | 8 | 65 | |
| Ivana Boďová | 23 | 13 | 7 | 8 | 71 | |
| Thomas Lechmere | 66 | 17 | 8 | 8 | 77 | |
| Paul Bosman | 6 | 14 | 9 | 6 | 52 | |
| Shirelle Burton-Fanning | 22 | 22 | 4 | 5 | 49 | |
| Teruaki Murakami | 10 | 14 | 3 | 7 | 42 | |
| Fátima Rodrigues Fernandes | 19 | 6 | 14 | 7 | 48 | |
| Carmela Giancotta | 20 | 34 | 11 | 11 | 61 | |
| Tamara Mateu‐Albero | 24 | 21 | 13 | 6 | 58 |
All Works
Login with ORCID to disown or claim papers
Loading papers...